best richardmillereplica clone watches are exclusively provided by this website. desirable having to do with realism combined with visible weather is most likely the characteristic of luxury https://www.patekphilippe.to. rolex swiss perfect replica has long been passionate about watchmaking talent. high quality www.youngsexdoll.com to face our world while on an start up thinking. reallydiamond.com on the best replica site.

Highly active antiretroviral therapy regimen change among HIV/AIDS patients in Boru Meda Hospital, Amhara Regional State, Ethiopia Advance Pharmaceutical Journal

Research Articles

2025  |  Vol: 10(3)  |  Issue: 3(May-June) | https://doi.org/10.31024/apj.2025.10.3.1
Highly active antiretroviral therapy regimen change among HIV/AIDS patients in Boru Meda Hospital, Amhara Regional State, Ethiopia

Abebaw Tegegne

B. Pharm, MSc (Pharmacology)

Pharmacy Department, Dessie Health Science College, Amhara, Ethiopia


Abstract

Background: Highly active antiretroviral therapy is the cornerstone of management of patients with human immunodeficiency virus infection. Antiretroviral therapy can improve quality of life and prolong patient’s survival; however they may cause a number of adverse effects; which may end with treatment failure and/or regimen changes. The aim of the study is to assess the reasons for antiretroviral regimen change among HIV/AIDS Patients in Boru meda general Hospital, ART Clinic. Methods: Hospital based retrospective cross sectional study was conducted at Boru meda general Hospital; HAART Clinic recorded from January 01, 2007 to January 30, 2018 by reviewing patients’ information sheets, medical records and laboratory results. Patients who changed their highly active antiretroviral therapy regimen included in the study. A structured questionnaire was used for data collection. Results: A total of 275 patients whose first line HAART drug regimen changed in BMH were reviewed. Above half (56.4%) of the patients in this study were females. The patients, 174(66.9%) were at the age groups between 30-45 years. During  initial  changes  toxicity  was  the  most  common  reason  182(66.2%)reported  followed  by33(12%) comorbidity, 25(9.1%) treatment  failure, 17(6.2%) pregnancy and16(5.8%) adherence  difficulty. Regarding to the initial regimen, 88(32%) patients were on D4T/3TC/NVP, 62(22.5%) were on D4T/3TC/EFV, 64(23.3%) were on AZT/3TC/NVP and 52(18.9%) were on AZT/3TC/EFV. Conclusion:  This study indicated that the main reasons for initial and second time ART regimen change were drug toxicity among the study population. Co-morbidity, treatment failure and pregnancy were the other reasons. Lipodystrophy, anemia, renal toxicity, vomiting and rash were among the most common leading toxicity causes for ART regimen change respectively.

Keywords: Boru meda general  hospital, HAART, Regimen change, Toxicity, Lipodystrophy

Manuscript Management System
Submit Article Subscribe Most Popular Articles Join as Reviewer Email Alerts Open Access